Is Keryx Biopharmaceuticals (KERX) Going to Burn These Hedge Funds?

Page 1 of 2

Keryx Biopharmaceuticals (NASDAQ:KERX) was in 6 hedge funds’ portfolio at the end of December. KERX investors should pay attention to a decrease in support from the world’s most elite money managers of late. There were 7 hedge funds in our database with KERX positions at the end of the previous quarter.

In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite money managers can trounce the S&P 500 by a solid amount (see just how much).

Keryx Biopharmaceuticals (NASDAQ:KERX)

Just as key, bullish insider trading activity is another way to break down the stock market universe. Just as you’d expect, there are lots of reasons for an insider to sell shares of his or her company, but only one, very clear reason why they would behave bullishly. Many academic studies have demonstrated the useful potential of this tactic if you understand what to do (learn more here).

With all of this in mind, we’re going to take a glance at the recent action encompassing Keryx Biopharmaceuticals (NASDAQ:KERX).

What does the smart money think about Keryx Biopharmaceuticals (NASDAQ:KERX)?

Heading into 2013, a total of 6 of the hedge funds we track held long positions in this stock, a change of -14% from the third quarter. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were boosting their stakes significantly.

According to our comprehensive database, Joseph Edelman’s Perceptive Advisors had the largest position in Keryx Biopharmaceuticals (NASDAQ:KERX), worth close to $3 million, accounting for 0.5% of its total 13F portfolio. Coming in second is Israel Englander of Millennium Management, with a $0.7 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other hedge funds that hold long positions include D. E. Shaw’s D E Shaw, and Cliff Asness’s AQR Capital Management.

Since Keryx Biopharmaceuticals (NASDAQ:KERX) has faced falling interest from the aggregate hedge fund industry, we can see that there were a few hedge funds that slashed their positions entirely at the end of the year. Intriguingly, John Burbank’s Passport Capital cut the largest position of the “upper crust” of funds we monitor, worth about $1.4 million in stock.. Chuck Royce’s fund, Royce & Associates, also cut its stock, about $0.7 million worth. These bearish behaviors are intriguing to say the least, as total hedge fund interest fell by 1 funds at the end of the year.

How are insiders trading Keryx Biopharmaceuticals (NASDAQ:KERX)?

Insider buying is most useful when the company in question has experienced transactions within the past 180 days. Over the last half-year time period, Keryx Biopharmaceuticals (NASDAQ:KERX) has seen zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Keryx Biopharmaceuticals (NASDAQ:KERX). These stocks are Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), Endocyte, Inc. (NASDAQ:ECYT), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). This group of stocks are in the drug manufacturers – major industry and their market caps resemble KERX’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!